TSUJIKAWA Masanori

Learn More
To evaluate the incidence and risk factors for secondary solid tumors in Japan after allogeneic hematopoietic SCT (allo-HSCT), 2062 patients who had received allo-HSCT between 1984 and 2005 were retrospectively analyzed. Twenty-eight patients who developed 30 solid tumors were identified a median of 5.6 years after transplantation. The risk for developing(More)
This paper introduces a technology of noise-robust speech recognition to correctly recognize a user’s speech even in places with a high level of background noise and immediately respond to it, together with applications of this technology. Voice UI is useful when the user’s hands or eyes are busy, but the background noise may cause false operations. The(More)
Anti-HNK-1 monoclonal antibody (MAb) was reactive with non-cancerous and cancerous prostatic epithelia, as well as natural killer cells, myelinated nerves and cells from APUD systems. The expression of HNK-1 antigen on prostate cancer was investigated immunohistochemically by avidinbiotin-peroxidase complex (ABC) method with anti-HNK-1 MAb to clarify the(More)
  • 1